Диссертация (1139581), страница 46
Текст из файла (страница 46)
165-166.169. Шабунин А.В., Лукин А.Ю., Шиков Д.В. Оптимальное лечение острогопанкреатита в зависимости от “модели” панкреонекроза // Анналыхирургической гепатологии. 2013; 18(3): 70-78.170. Шаповальянц С.Г., Федоров Е.Д., Будзинский С.А., Котиева А.Ю.Стентированиепротокаподжелудочнойжелезывлеченииострогопанкреатита после эндоскопических транспапиллярных вмешательств //Анналы хирургической гепатологии.
2014; 19(1): 17-27.171. ШевчукИ.М.,КузенкоР.Т.,ЯворскийМ.И.Хирургическиевмешательства при остром панкреатите у больных старшей возрастнойгруппы // Хирургия Восточная Европа. 2013; 1(5): 6-11.172. Яковлева З.А., Дохунаев В.В., Тяптиргянова Т.М. Эндоскопическиевмешательства при патологии гепатопанкреатобилиарной зоны // Якутскиймедицинский журнал 2013; 3: 51-53.173. ЯрОР А.Л., Долгарева С.А., Локтионов А.Л., Конопля А.И. Коррекциянарушений структурно-функциональных свойств эритроцитов и иммунного293статуса у больных с острым билиарным панкреатитом // Системный анализ иуправление в биомедицинских системах 2010; 9(4): 847-851.174. Ярощук С.А., Короткевич А.Г., Леонтьев А.С.
Диагностическиепараллели в диагностике острого билиарного панкреатита // Медицина вКузбассе. 2014; 1: 71-74.175. Abdel Aziz A.M., Lehman G.A.: Pancreatitis after endoscopic retrogradecholangiopancreatography. World J Gastroenterol 2007; 13(19):2655-2668.176. Ahlers O., Nachtigall I., Lenze J. et al. Intraoperative thoracic epiduralanaesthesia attenuates stress-induced immunosuppression in patients undergoingmajor abdominal surgery. Br. J. Anaest.
2008; 101(6): 781 – 787.177. Al Mofleh I.A. Severe acute pancreatitis: pathogenetic aspects andprognostic factors. World J. Gastroenterol. 2008; 14(5): 675-684.178. Alhajeri A., Erwin S. Acute pancreatitis: value and impact of CT severityindex. Abdominal Imaging 2008; 33(1): 18-20.179. AndriulliA.,AnneseV.Riskofpost-endoscopicretrogradecholangiopancreatography pancreatitis and ways to prevent it: old myths, a currentneed? The case of allopurinol. Clin Gastroenterol Hepatol 2008; 6: 374–376.180.Andriulli A., Clemente R., Solmi L.
et al. Gabexate or somatostatinadministration before ERCP in patients at high risk for post-ERCP pancreatitis: amulticenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc2002; 56: 488–495.181.Andriulli A., Forlano R., Napolitano G. et al. Pancreatic duct stents in theprophylaxisofpancreaticdamageafterendoscopicretrogradecholangiopancreatography: a systematic analysis of benefits and associated risks.Digestion 2007; 75: 156–163.182.Andriulli A., Solmi L., Loperfido S. et al. Prophylaxis of ERCP-relatedpancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.Clin Gastroenterol Hepatol 2004; 2: 713–718.294183.Arcidiacono R., Gambitta P., Rossi A.
et al. The use of a long-actingsomatostatin analogue (octreotide) for prophylaxis of acute pancreatitis afterendoscopic sphincterotomy. Endoscopy 1994; 26: 715–718.184. Arkadopoulos N., Defterevos G., Nastos C. et al. Development of a porcinemodel of post-hepatectomy liver failure. Journal of Surgical Research 2011;170(2): 233-242.185.Arkadopoulos N., Nastos C., Defterevos G., Kalimeris K., Papoutsidakis N.,Andreadou I.
Pancreatic injury after major hepatectomy: a study in a porcinemodel. Surgery Today 2012; 42(4): 368-375.186. Arvanitidis D., Anagnostopoulos G.K., Giannopoulos D. et al. Cansomatostatin prevent post-ERCP pancreatitis? Results of a randomized controlledtrial. J Gastroenterol Hepatol 2004; 19: 278–282.187. Attasaranya S., Cheon Y., Vittal H. et al. Large-diameter biliary orificeballoon dilation to aid in endoscopic bile duct stone removal: a multicenter series.Gastrointest Endosc 2008; 67: 1046–1052.188.
Babu B.I., Genovese T., Mazzon E. et al. Recombinant human activatedprotein C, (Xigris) attenuated murine cerulein-induced acute pancreatitis viaregulation of nuclear factor κB and apoptotic pathways Pancreas 2012; 41(4): 619628.189. Bai Y, Gao J, Zhang W, Zou D, Li Z. Meta-analysis: allopurinol in theprevention of postendoscopic retrograde cholangiopancreatography pancreatitis.Aliment Pharmacol Ther 2008; 28: 557–564.190. Bai Y., Gao J., Shi X., Zou D., Li Z.
Prophylactic corticosteroids do notprevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.Pancreatology 2008; 8: 504–509.191. Bakker O.J., et al.Prevention, detection, and management of infectednecrosis in severe acute pancreatitis. Curr. Gastroenterol. Rep. 2009; 11(2): 104110.192. Balthazar E.J., et al. Acute pancreatitis: value of CT in establishingprognosis. Radiology 1990; 174: 331-336.295193.
Bang U.C., Nojgaard C., Andersen P.K., Matzen P. Meta-analysis:Nitroglycerin for prevention of post-ERCP pancreatitis. Aliment Pharmacol Ther2009; 29: 1078–1085.194. Banks P.A., Freeman M.L. Practice guidelines in acute pancreatitis. Am JGastroenterol 2006; 101: 2379-2400.195. Barkay O., Niv E., Santo E.
et al. Low-dose heparin for the prevention ofpost-ERCP pancreatitis: A randomized placebo-controlled trial. Surg. Endosc.2008; 22: 1971–1976.196. Baron T.H., Harewood G.C. Endoscopic balloon dilation of the biliarysphincter compared to endoscopic biliary sphincterotomy for removal of commonbile duct stones during ERCP: a metaanalysis of randomized, controlled trials. AmJ Gastroenterol 2004; 99: 1455–1460.197. Barreto S.G., Carati C.J., Schloithe A.C., Toouli J., Saccone G.T. Octreotidenegates the benefit of galantide when used in the treatment of caerulein-inducedacute pancreatitis in mice.
HPB (Oxford) 2010; 12: 403-411.198. Barreto S.G., Rodrigues J. Comparison of SOFA and Imrie Scoring Systemsin predicting the severity of Acute Pancreatitis. World J Emerg Surg 2007; 2: 33.199. Beene E., Brown L., Connor S. A comparison of the hospital costs of openvs. minimally invasive surgical management of necrotizing pancreatitis. HPB2011; 13: 178-184.200. Beger H.G., Rau B.M. Severe acute pancreatitis: clinical course andmanagement. World Journal of Gastroenterology 2007; 13(38): 5043-5051.201. Benvenutti S., Zancanella L., Piazzi L. et al.
Prevention of post-ERCPpancreatitis with somatostatin versus gabexate mesylate: A randomized placebocontrolled multicenter study. Dig Liv Dis 2006; 38: S15.202. Besselink M.G., van Santvoort H.C., Boermeester M.A., Nieuwenhuijs V.B.,van Goor H., Dejong C.H., Schaapherder A.F., Gooszen H.G. Timing and impactof infections in acute pancreatitis.
Br J Surg 2009; 96: 267-273.296203. Besselink M.G., Verwer T.J., Schoenmaeckers E.J., Buskens E., RidwanB.U., Visser MR et al. Timing of surgical intervention in necrotizing pancreatitis.Arch Surg 2007; 142: 1194-1201.204. Bollen T.L., van Santvoort H.C., Besselink M.G., van Leeuwen M.S.,Horvath K.D., Freeny P.C. et al. The Atlanta Classification of acute pancreatitisrevisited.
Br J Surg 2008; 95: 6–21.205. Booth D. M., Mukherjee R., Sutton R., Criddle D. N. Calcium and reactiveoxygen species in acute pancreatitis. Friend or foe?” Antioxidants & RedoxSignaling 2011; 15(10): 2683-2698.206. Booth D.M., Murphy J.A., Mukherjee R., Tepikin A.V., Criddle D.N.,Awais M., Neoptolemos J.P., Sutton R., Gerasimenko O.V., Petersen O.H.Reactive oxygen species induced by bile acid induce apoptosis and protect againstnecrosis in pancreatic acinar cells.
Gastroenterology 2011; 140(7): 2116-2125.207. Bradley, E.L.III. A clinically based classification system for acutepancreatitis. Summary of the International Symposium on Acute Pancreatitis,Atlanta, Ga, 11–13 Sept., 1992. Arch. Surg 1993; 128: 586-590.208. Bradley, E.L.III. A clinically based classification system for acutepancreatitis. Ann. Chir. 1993; 47: 537-541.209. Bretthauer M., Seip B., Aasen S.
et al. Carbon dioxide insufflation for morecomfortable endoscopic retrograde cholangiopancreatography: a randomized,controlled, double-blind trial. Endoscopy 2007; 39: 58–64.210.211. British Society of Gastroenterology. United Kingdom guidelines for themanagement of acute pancreatitis. Gut.
1998; 42(Suppl. 2): 1-13.212. Bucher P., Pugin F., Morel P. Minimally invasive necrosectomy for infectednecrotizing pancreatitis. Pancreas 2008; 36: 113-119.213. Burch J.M. et al. The abdominal compartment syndrome. Surg. Clin. North.Am. 1996; 76(4): 833–842.297214. Calhoun K., Lin A., Bryant-Greenwood P., Lum C., Johnson D., et al. Fieldhistology point care microscopic technique. Archives of Pathology & LaboratoryMedicine 2011; 135: 207-210.215. Cavallini G., Tittobello A., Frulloni L. et al.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
